Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 381-390 of 531 for center for individualized medicine

Edit search filters
  1. A Study to Predict Response to Virotherapy and Immunotherapy by Using an Ex-Vivo Three-Dimensional Patient-Derived Organoid Model of Pediatric Urological Cancers

    Rochester, MN

  2. A Study to Identify Biomarkers in the Blood, Saliva or Tissue for Oropharyngeal Squamous Cell Cancer

    Rochester, MN

  3. A Study of Genes that cause Cystic Kidney Disease

    Rochester, MN

  4. Diagnostic and Prognostic Validity of Tissue-based Biomarker Assay for Acute Graft-versus-host Disease of the Skin: A Retrospective Study

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. Epilepsy Genetics Initiative (EGI)

    Rochester, MN

  6. Treatment of Multifocal Lung Adenocarcinoma

    Rochester, MN

  7. Validation of a Blood Assay for the Detection of BRAF Mutation Status in Patients with Metastatic Melanoma

    Rochester, MN

  8. A Study of Blood Clotting Response in Patients with a Traumatic Injury

    Rochester, MN

  9. A Study of Clinical Symptoms in PMM2 Patients Affected by mtDNA Variants and Haplotypes

    Rochester, MN

  10. Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL)

    Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer